Eli Lilly and Company is finally entering the #Alzheimer’s arena with the FDA approval of its anti-amyloid therapy #Kisunla. Read more about the drug, which will be going up against Biogen and Eisai’s Leqembi: https://buff.ly/3LaoUKj #FDAApproval #AlzheimersDisease #NeurodegenerativeDiseases #BetaAmyloid #AmyloidBeta #AntiAmyloidTherapy #MonoclonalAntibody #EliLilly #Neuroscience #Neurology
Xtalks’ Post
More Relevant Posts
-
🚀 Join Anlitiks Inc. for an enlightening webinar exploring the impact of #RealWorldData and evidence in regulatory approvals and drug commercialization. Discover strategies to mitigate risks and ensure the reliability of real-world data, and explore how it can expedite clinical trials and inform critical decisions. Learn techniques to enhance patient recruitment, refine study designs, and validate hypotheses, while demonstrating real-world effectiveness to stakeholders. ➡️ More info + register here: https://buff.ly/3xHkzLH Featured speakers: Stephanie Butler Kitty Rajagopalan #DrugDevelopment #DataAnalytics #RealWorldEvidence #Commercialization
To view or add a comment, sign in
-
-
💡 Join Syneos Health for an informative webinar focused on strategies and insights needed to comply with the Inflation Reduction Act (IRA) and capitalize on its new provisions for drug development, pricing, and market access in the biopharmaceutical industry. Attendees will: ✅ Learn new compliance requirements and regulatory adjustments ✅ Explore the IRA's impact on drug development, pricing, and market access ✅ Discover strategic planning techniques to drive innovation while maintaining compliance 📌 Learn more + register here: https://buff.ly/3xRHhR8 🌟 Featured speakers: Tiffany M. Peter Yixiao Zou, Ph.D. #DrugDevelopment #PharmaceuticalManufacturing #Commercialization #HEOR #MarketAccess
To view or add a comment, sign in
-
-
Navigating the Joint Clinical Assessment (JCA) Landscape: A Strategic ...
www.linkedin.com
To view or add a comment, sign in
-
The newly authorized Xpert HCV (hepatitis C virus) test by Cepheid is designed for use in point-of-care settings and brings new hope for those living with hepatitis C. Learn more about this test-and-treat diagnostic innovation: https://buff.ly/4cFrJzm #HepatitisCTest #PointofCare #PointofCareTesting #HCV #HCVTesting #MedicalDevices #HCVElimination
New HCV Test Enables Diagnosis and Treatment in a Single Visit
xtalks.com
To view or add a comment, sign in
-
💡 Join HitGen Inc.'s upcoming webinar to discover how DNA-encoded libraries are revolutionizing early-stage, small-molecule drug discovery, especially for targeting G protein-coupled receptors (#GPCRs). 🧬 Learn about the remarkable advancements and impact of #DNAEncodedLibrary in identifying hit compounds for #DrugDevelopment. The expert speakers, Alex Shaginian, PhD, MBA, Rusty Montgomery, and David Israel will cover the unique advantages of DNA-encoded libraries for various targets and provide an overview of different platforms and their applications in drug discovery. BioAge Labs will also share insights from their study on novel indazole #NLRP3 inhibitors, demonstrating the selection strategy and analysis of small molecule structures and activities. ➡️ REGISTER HERE: https://buff.ly/3WeHJCo #SmallMolecule #DrugDevelopment #DrugDiscovery #DrugManufacturing #SmallMoleculeDrug
To view or add a comment, sign in
-
-
🌟💬 Xtalks Spotlight: Ensuring compliance and maintaining high-quality standards in clinical trials is paramount. Steven Begley, Chief Compliance Officer at YPrime, shared his innovative approach to quality management and compliance with Xtalks. ⏩ Watch and read the full interview with Steve Begley to learn more: https://buff.ly/4cwnUwh #ClinicalTrials #ClinicalResearch #ClinicalDevelopment #QualityManagement #QualityCompliance #XtalksSpotlight
To view or add a comment, sign in
-
The medical device and medtech industry is undergoing significant changes, which is evident in the rising value of the global medical devices market from approximately $542.2 billion in 2024 to $886 billion by 2032. Read more to learn about the top 10 trends for the medical device and medtech industry in 2024: https://buff.ly/4cduhEE #MedicalDevice #MedTech #AI #MachineLearning #WearableDevice #WearableTechnology #WearableDevices #HealthWearables #RemotePatientMonitoring
Top 10 Medical Device and MedTech Trends in 2024
xtalks.com
To view or add a comment, sign in
-
The US Food and Drug Administration (FDA)’s new draft guidance aims to boost clinical trial diversity, aiming to make medical research more inclusive. Read more about how this impacts patient care and treatment effectiveness: https://buff.ly/45YnhZZ+ #FDADraftGuidance #ClinicalTrials #DiversityInClinicalTrials #ClinicalTrialDiversity #PatientDiversity #MedicalProducts #HealthEquity
Enhancing Clinical Trial Diversity: FDA’s New Draft Guidance on Enrollment Plans
xtalks.com
To view or add a comment, sign in
-
💡 Join HitGen Inc.'s upcoming webinar to discover how DNA-encoded libraries are revolutionizing early-stage, small-molecule drug discovery, especially for targeting G protein-coupled receptors (#GPCRs). 🧬 Learn about the remarkable advancements and impact of #DNAEncodedLibrary in identifying hit compounds for #DrugDevelopment. The expert speakers, Alex Shaginian, PhD, MBA, Rusty Montgomery and David Israel will cover the unique advantages of DNA-encoded libraries for various targets and provide an overview of different platforms and their applications in drug discovery. BioAge Labs will also share insights from their study on novel indazole #NLRP3 inhibitors, demonstrating the selection strategy and analysis of small molecule structures and activities. ➡️ REGISTER HERE: https://buff.ly/3WeHJCo #SmallMolecule #DrugDevelopment #DrugDiscovery #DrugManufacturing #SmallMoleculeDrug
To view or add a comment, sign in
-
-
Advancing Clinical Research Through Hybrid Clinical Trials and Patient ...
www.linkedin.com
To view or add a comment, sign in